Literature DB >> 2786408

The grading and prevalence of macular degeneration in Chesapeake Bay watermen.

N M Bressler1, S B Bressler, S K West, S L Fine, H R Taylor.   

Abstract

A new grading scheme was developed to classify the fundus features of macular degeneration. This scheme identifies the earliest fundus changes associated with macular degeneration, as well as specific drusen characteristics felt to be associated with an increased risk of developing the exudative forms of this disease. Agreement between two graders using this scheme indicated good interobserver reliability. Using this scheme, fundus photographs of 777 participants were graded in a population-based study of watermen from the eastern shore of Maryland. The prevalence of at least one druse within 1500 microns of the foveal center was extremely common (over 80% in each age group over 30 years of age) and not age related. The prevalence of large, confluent, or soft drusen was relatively uncommon and was age related; by the eighth decade, 26% of all participants had large or soft drusen, and 17% of them had confluent drusen. These latter characteristics are more likely to be markers of early changes consistent with age-related macular degeneration rather than simply the presence of a few drusen.

Entities:  

Mesh:

Year:  1989        PMID: 2786408     DOI: 10.1001/archopht.1989.01070010869032

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  46 in total

1.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study.

Authors:  S H Sarks; J J Arnold; M C Killingsworth; J P Sarks
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

2.  "Oxidative protector" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration.

Authors:  R N Frank
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 3.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

4.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

Review 5.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope.

Authors:  Henrike Wüstemeyer; Andreas Moessner; Cornelia Jahn; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

7.  Macular degeneration: how big is the problem?

Authors:  E Cheraskin
Journal:  J Natl Med Assoc       Date:  1992-10       Impact factor: 1.798

8.  Serum levels of antioxidants and age-related macular degeneration.

Authors:  N C Tsang; P L Penfold; P J Snitch; F Billson
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

9.  Visible light and risk of age-related macular degeneration.

Authors:  H R Taylor; B Muñoz; S West; N M Bressler; S B Bressler; F S Rosenthal
Journal:  Trans Am Ophthalmol Soc       Date:  1990

10.  Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.

Authors:  S Y Cohen; L Dubois; R Tadayoni; C Delahaye-Mazza; C Debibie; G Quentel
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.